BCWORLD PHARM. Co. Ltd (200780) — Cash Flow Reinvestment Rate
BCWORLD PHARM. Co. Ltd (200780) has a Cash Flow Reinvestment Rate of 1.95x as of September 2025, reinvesting ₩2.79 Billion (capex ₩1.63 Billion plus investments ₩-1.16 Billion) from operating cash flow of ₩1.43 Billion. Explore BCWORLD PHARM. Co. Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BCWORLD PHARM. Co. Ltd Cash Flow Reinvestment Rate (2015–2024)
Historical reinvestment intensity for BCWORLD PHARM. Co. Ltd across 8 annual periods. Also explore how large is BCWORLD PHARM. Co. Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for BCWORLD PHARM. Co. Ltd (2015–2024)
Year-by-year capital reinvestment analysis for BCWORLD PHARM. Co. Ltd. For live market cap and broader valuation context, see BCWORLD PHARM. Co. Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.88x | ₩3.55 Billion | ₩4.04 Billion | ₩2.41 Billion | ▲ +48.2% |
| 2023 | 0.59x | ₩6.47 Billion | ₩10.94 Billion | ₩2.71 Billion | ▼ -42.5% |
| 2022 | 1.03x | ₩7.08 Billion | ₩6.88 Billion | ₩6.22 Billion | ▼ -42.8% |
| 2019 | 1.80x | ₩21.76 Billion | ₩12.11 Billion | ₩21.32 Billion | ▼ -69.1% |
| 2018 | 5.81x | ₩31.03 Billion | ₩5.34 Billion | ₩29.92 Billion | ▲ +176.2% |
| 2017 | 2.10x | ₩16.62 Billion | ₩7.90 Billion | ₩16.58 Billion | ▼ -96.0% |
| 2016 | 52.54x | ₩12.80 Billion | ₩243.66 Million | ₩12.56 Billion | ▲ +1726.7% |
| 2015 | 2.88x | ₩25.26 Billion | ₩8.78 Billion | ₩25.26 Billion | — |